130.1 ð é«åžçç
130.1.0.1 ð äžé éé»
- Travel clinic äžå€§æ¯æ±:
- Vaccines (äŸç®çå°: yellow fever, typhoid, Hep A/B, JEV, rabies, polio, meningococcal, cholera)
- Malaria prophylaxis (åå + æè¥ â atovaquone-proguanil / doxycycline / mefloquine)
- Travelerâs diarrhea (food/water hygiene + self-treatment kit)
- åžžèŠååçŒç: malaria (#1), dengue, typhoid, viral hepatitis, leptospirosis, rickettsia
- Pre-travel timing: 4-6 é±å (æäº vaccine éå€å)
130.1.0.2 1ïžâ£ Vaccines for Travelers
| ç«è | å°è±¡ | åå |
|---|---|---|
| Yellow Fever | Endemic country travel | Sub-Saharan Africa, S. America (Brazil, Peru) |
| Typhoid (Vi inj or Ty21a oral) | Developing country, S. Asia é«é¢šéª | India, Pakistan, Bangladesh |
| Hep A | Any developing country | Universal |
| Hep B | If extended stay, sex, medical procedures | Asia, Africa |
| Polio booster | If travel to endemic / outbreak | Pakistan, Afghanistan |
| Meningococcal ACWY | Hajj, sub-Saharan meningitis belt, college dorm US | |
| Men B | Outbreak, military, college outbreaks | |
| JEV | Rural Asia >1 month | India, SE Asia, China |
| Cholera (oral) | Endemic + extended stay | Bangladesh, Haiti |
| Rabies pre-exposure | High-risk (veterinarian, animal handler, prolonged rural) | Asia, Africa |
130.1.0.3 2ïžâ£ Malaria Prophylaxis
ð äžææŠå¿µèªªæïŒMalaria é é²éžè¥äž»èŠçäžåè®æž â (1) ç®çå°æè¥ pattern (倧éšåå°å chloroquine 已倱æïŒåªæäžçŸæŽ²ãå 忝ãéšåäžæ±ä»ææ)ã(2) è¡çšé·ç (çæ atovaquone-proguanil ææ¹äŸ¿ãé·æ doxycycline 䟿å®)ã(3) ç 人 comorbidity (mefloquine 粟ç¥ç å²çŠçšãtafenoquine/primaquine éå é© G6PD)ãéé»èšæ¶ïŒAtovaquone-proguanil = first-line, åºçŒå 1-2 倩éå§, åååŸåªèŠ 7 倩ïŒå ¶ä»è¥éœèŠ 4 é±ïŒâ åºååå¿èšåè¥ç traveler ææå°±æ¯å®ãå人é²è· (DEET + permethrin + bed net) èè¥ç©åçéèŠ â malaria mosquito äžå¬å°±äžæææïŒéæ¯ stewardship + é²è·çéä¿éªã
130.1.0.3.1 颚éªå
- High: sub-Saharan Africa, parts of SE Asia (Myanmar borders, PNG)
- Moderate: India, Indonesia, Philippines (rural), Brazil Amazon
- Low: most urban Asia, S. America cities
130.1.0.3.2 è¥ç©éžæ (äŸæè¥ pattern)
| è¥ç© | Dosing | èµ·æé | æçº | é©çš |
|---|---|---|---|---|
| Atovaquone-proguanil (Malarone) | 1 tab daily | 1-2 d before | 7 d after return | All regions; first-line |
| Doxycycline | 100 mg daily | 1-2 d before | 4 weeks after | All regions; cheap; SE photosensitivity |
| Mefloquine | 1 tab weekly | 2-3 wk before | 4 weeks after | Areas without mefloquine resistance; avoid in psychiatric history (neuropsychiatric SE) |
| Chloroquine | weekly | 1-2 wk before | 4 weeks after | Limited use â most regions resistant |
| Tafenoquine (Krintafel/Arakoda) | weekly post-loading | loading 3 d | 7 d after | New 2018; G6PD test required (hemolysis) |
| Primaquine | daily 30 mg | 1-2 d before | 7 d after | P. vivax / P. ovale (radical cure for liver hypnozoites); G6PD test |
130.1.0.4 3ïžâ£ Travelerâs Diarrhea
- 60-80% on tropical travel
- Pathogens: ETEC (most common), EAEC, Campylobacter, Shigella, Salmonella, Norovirus, Giardia, Cryptosporidium
- Prevention: âBoil it, cook it, peel it, or forget itâ; Pepto-Bismol bid (mild)
- Self-treatment kit:
- Loperamide (Imodium) 4 mg loading + 2 mg per stool (max 16 mg/d) â symptomatic
- Antibiotic (azithromycin 1g single dose preferred â over Cipro due rising resistance) for moderate-severe (⥠3 stools/24 hr + symptoms)
- Oral rehydration
130.1.0.5 4ïžâ£ Returned Traveler with Fever
ð äžææŠå¿µèªªæïŒReturned traveler çŒç第äžé奿°žé æ¯ malaria â smear à 3 (q12h) æ¯é»éæšæºïŒå次 negative ä¹èŠéè€ïŒå çº parasitemia æ cyclical patternã第äºåžžèŠïŒdengue (äºæŽ²/åçŸ/å 忝, åŸçŒç + ç®ç¹ + è¡å°æ¿äœ)ãtyphoid (åäº sustained fever)ãHep A (developing country)ãleptospirosis (淹氎 / æ²³é)ãrickettsia (eschar)ãschistosomiasis (4-8 é± acute Katayama)ãæœäŒææ¯éèŠç·çŽ¢ â ç (< 14 倩) æ³ dengue / lepto / rickettsiaïŒäž (2-3 é±) æ³ malaria / typhoidïŒé· (> 30 倩) æ³ P. vivax åŸ©çŒ / Hep B / schistoãéå ±çŸ©åïŒå°ç£ malaria + dengue + typhoid + Zika + Mpox éœæ¯æ³å®éå ±å³æç ïŒååçŒç + æ éå²å¿ é éå ±çŸç®¡çœ²ã
130.1.0.5.1 High-yield éå¥ (éé»ïŒ)
| çŸç | åå | æœäŒæ | ç¹åŸµ |
|---|---|---|---|
| Malaria (#1) | æåæä»¥åéæŽ², SE Asia | 7-30 d (longer P. vivax) | çŒç, é ç, å¯é¡«, é»çž; smear |
| Dengue | Asia, S. America, Caribbean | 4-14 d | çŒç, é ç, åŸçŒç, ç®ç¹ (sunburn-like), thrombocytopenia |
| Typhoid | S. Asia | 7-21 d | Sustained fever, rose spots, bradycardia, GI |
| Viral hepatitis A | Any developing | 15-45 d | Jaundice, fatigue, transaminase ââ |
| Leptospirosis | Tropics, swimming, flooding | 7-14 d | Fever, conjunctival suffusion, AKI, jaundice |
| Rickettsia (RMSF, scrub typhus) | Forest, ticks | 5-14 d | Fever, rash, eschar |
| Schistosomiasis | Africa (Nile, Lake Malawi), S. America | 4-8 wk after exposure | Acute Katayama fever |
| Mpox | Central/W. Africa, MSM exposure | 5-21 d | Vesicular rash, lymphadenopathy |
130.1.0.5.2 Initial workup
- CBC (eosinophilia â parasite), platelets (low â dengue, malaria)
- LFT, BUN/Cr
- Blood cultures à 3
- Malaria smear à 3 (q12h) â å¿ å! ; rapid antigen test (HRP-2)
- Dengue NS1 antigen + IgM/IgG
- Stool: O&P, PCR multiplex
- HBV/HCV serology
- Rickettsia, leptospirosis serology if suspect